Patients suffering from a range of debilitating illnesses, such as spinal cord injury, cerebral palsy, optic nerve hypoplasia, multiple sclerosis and ataxia stand to benefit from a new laboratory, established with a Chinese Government grant. Such a facility will put China at the forefront of the global race to engineer and reprogram human stem cells for positive medical benefit.
SHENZHEN, China – Beike Biotechnology, (http://www.beikebiotech.com), the leader in stem cell applications for medical treatment, has announced that i ... |
